BPO TV

In this episode of From the Helm, Grady is joined by Clarity Pharmaceuticals (ASX:CU6) Executive Chairperson Alan Taylor & Bell Potter Senior Analyst John Hester, for a deep dive into their next-generation radiopharmaceutical technology for both early-stage cancer diagnosis and treatment.